| Cole Uhland, MD | |
|
5555 E Camino Del Celador, Tucson, AZ 85750-1822 | |
| (720) 470-0042 | |
| Not Available |
| Full Name | Cole Uhland |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 5555 E Camino Del Celador, Tucson, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760003727 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | DR.0071639 (Colorado) | Secondary |
| 207R00000X | Internal Medicine | R78097 (Arizona) | Primary |
| Entity Name | Catholic Health Initiatives Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356783351 PECOS PAC ID: 8022927342 Enrollment ID: O20031215000462 |
News Archive
Merus Labs International Inc. is pleased to announce today that the syndicate of investment dealers (the "Underwriters") has exercised the over-allotment option to purchase 1,000,550 common shares of the Company ("Shares") at a price of C$3.05 per Share granted to the Underwriters in connection with the Company's previously announced public offering which closed on April 30, 2015.
Allergy specialists like Dr. Shelly Harvey are again readying themselves for mountain cedar, the annual irritant that makes noses run and eyes itch – potentially transforming the merriest of holiday well-wishers into miserable Ebenezer Scrooges.
Presidio Pharmaceuticals, Inc. announced today the successful completion of a Phase 1a clinical trial of PPI-461, its lead HCV NS5A inhibitor, in healthy subjects. This first-in-human trial evaluated four single doses of PPI-461, followed by a five-day, once-a-day treatment regimen with PPI-461 at the highest tested dose.
Synthego, a leading provider of genome engineering solutions, today announces the world's first synthetic single guide RNA (sgRNA) CRISPR genome editing kit.
X-BODY BioSciences, a developer of human monoclonal antibody therapeutics, today announced it has been awarded a research grant under the Patient Protection and Affordable Care Act of 2010 for its human monoclonal antibody therapeutic project targeting metastatic tumor stem cells.
› Verified 3 days ago
| Entity Name | Portercare Adventist Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760761928 PECOS PAC ID: 0941110886 Enrollment ID: O20090115000327 |
News Archive
Merus Labs International Inc. is pleased to announce today that the syndicate of investment dealers (the "Underwriters") has exercised the over-allotment option to purchase 1,000,550 common shares of the Company ("Shares") at a price of C$3.05 per Share granted to the Underwriters in connection with the Company's previously announced public offering which closed on April 30, 2015.
Allergy specialists like Dr. Shelly Harvey are again readying themselves for mountain cedar, the annual irritant that makes noses run and eyes itch – potentially transforming the merriest of holiday well-wishers into miserable Ebenezer Scrooges.
Presidio Pharmaceuticals, Inc. announced today the successful completion of a Phase 1a clinical trial of PPI-461, its lead HCV NS5A inhibitor, in healthy subjects. This first-in-human trial evaluated four single doses of PPI-461, followed by a five-day, once-a-day treatment regimen with PPI-461 at the highest tested dose.
Synthego, a leading provider of genome engineering solutions, today announces the world's first synthetic single guide RNA (sgRNA) CRISPR genome editing kit.
X-BODY BioSciences, a developer of human monoclonal antibody therapeutics, today announced it has been awarded a research grant under the Patient Protection and Affordable Care Act of 2010 for its human monoclonal antibody therapeutic project targeting metastatic tumor stem cells.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cole Uhland, MD 7958 Centrebridge Dr, Niwot, CO 80503-7212 Ph: () - | Cole Uhland, MD 5555 E Camino Del Celador, Tucson, AZ 85750-1822 Ph: (720) 470-0042 |
News Archive
Merus Labs International Inc. is pleased to announce today that the syndicate of investment dealers (the "Underwriters") has exercised the over-allotment option to purchase 1,000,550 common shares of the Company ("Shares") at a price of C$3.05 per Share granted to the Underwriters in connection with the Company's previously announced public offering which closed on April 30, 2015.
Allergy specialists like Dr. Shelly Harvey are again readying themselves for mountain cedar, the annual irritant that makes noses run and eyes itch – potentially transforming the merriest of holiday well-wishers into miserable Ebenezer Scrooges.
Presidio Pharmaceuticals, Inc. announced today the successful completion of a Phase 1a clinical trial of PPI-461, its lead HCV NS5A inhibitor, in healthy subjects. This first-in-human trial evaluated four single doses of PPI-461, followed by a five-day, once-a-day treatment regimen with PPI-461 at the highest tested dose.
Synthego, a leading provider of genome engineering solutions, today announces the world's first synthetic single guide RNA (sgRNA) CRISPR genome editing kit.
X-BODY BioSciences, a developer of human monoclonal antibody therapeutics, today announced it has been awarded a research grant under the Patient Protection and Affordable Care Act of 2010 for its human monoclonal antibody therapeutic project targeting metastatic tumor stem cells.
› Verified 3 days ago
Dr. Basel Skeif, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5140 E Glenn St, Tucson, AZ 85712 Phone: 520-838-3540 Fax: 520-325-3526 | |
Dr. David Spencer Hamilton Sr., MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3601 S 6th Ave, Tucson, AZ 85723 Phone: 520-792-1450 | |
Diana Silva Cantillo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1230 S Cherrybell Stra, Tucson, AZ 85713 Phone: 520-628-8287 | |
Basel Shoua, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2070 W Rudasill Rd Ste 130, Tucson, AZ 85704 Phone: 520-797-4468 Fax: 520-797-4502 | |
Hadil Owaynat, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 1501 N Campbell Ave Rm 6336, Tucson, AZ 85724 Phone: 520-626-2760 Fax: 520-626-6020 | |
Dr. David M Schwartz, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6200 N La Cholla Blvd, Tucson, AZ 85741 Phone: 520-469-8011 Fax: 520-469-8021 | |
Kenneth Alex Murachanian, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6060 N Fountain Plaza Dr Ste 270, Tucson, AZ 85704 Phone: 520-229-2578 |